Farallon Capital Management, L.L.C. / RVMD
Farallon Capital Management, L.L.C.’s Revolution Medicines Inc Position
Does Farallon Capital Management, L.L.C. own Revolution Medicines Inc (RVMD)? Yes — 13.60M shares worth $1.3B (+7.18% of its 13F portfolio) as of Q1 2026, down from 14.58M shares the prior filed quarter.
Position Value
$1.3B
Q1 2026
Shares
13.60M
% of Portfolio
+7.18%
Quarters Held
22
currently held
Position History RVMD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 13.60M | $1.3B | +7.18% |
| Q4 2025 | 14.58M | $1.2B | +5.48% |
| Q3 2025 | 14.63M | $683M | +2.80% |
| Q2 2025 | 14.33M | $527M | +2.22% |
| Q1 2025 | 13.53M | $479M | +2.56% |
| Q4 2024 | 13.25M | $579M | +2.94% |
| Q3 2024 | 11.32M | $513M | +2.49% |
| Q2 2024 | 9.76M | $379M | +1.78% |
| Q1 2024 | 7.51M | $242M | +1.10% |
| Q4 2023 | 6.74M | $193M | +0.85% |
| Q3 2023 | 3.33M | $92M | +0.40% |
| Q2 2023 | 2.78M | $74M | +0.42% |
| Q1 2023 | 3.28M | $71M | +0.35% |
| Q4 2022 | 1.70M | $40M | +0.27% |
| Q3 2022 | 2.50M | $49M | +0.27% |
| Q2 2022 | 3.25M | $63M | +0.36% |
| Q1 2022 | 3.25M | $83M | +0.36% |
| Q4 2021 | 2.75M | $69M | +0.36% |
| Q3 2021 | 2.75M | $76M | +0.36% |
| Q2 2021 | 2.50M | $79M | +0.33% |
| Q1 2021 | 1.61M | $74M | +0.41% |
| Q1 2020 | 20.7K | $454,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of RVMD.